Abstract
Recent studies have shown that there is an interaction between fat and bone metabolisms. Adipose tissue secretes leptin and adiponectin to regulate bone metabolism. Leptin inhibits bone formation by activating the sympathetic nervous system, whereas the peripheral pathway of leptin shows a positive effect on bone formation. Opposite to leptin, adiponectin enhances or inhibits bone formation osteoblast in the central or peripheral respectively. On the other hand, osteocalcin (OCN) is decarboxylated and released from skeleton as the hormonal form of undercarboxylated-osteocalcin (ucOCN) to stimulate islets and fat to secret insulin and adiponectin respectively, thus to regulate energy metabolism. All these data indicate that there exist complex regulatory loops within fat and bone endocrine networks. In this review, we will elucidate the hormones and their receptors that mediate the communication between fat and bone metabolisms.
Keywords: Adiponectin, bone metabolism, fat metabolism, leptin, osteocalcin.
Current Signal Transduction Therapy
Title:Hormones and their Receptors Bridge Fat and Bone Metabolisms
Volume: 10 Issue: 1
Author(s): Chunyu Wang, Li Tian and Xijie Yu
Affiliation:
Keywords: Adiponectin, bone metabolism, fat metabolism, leptin, osteocalcin.
Abstract: Recent studies have shown that there is an interaction between fat and bone metabolisms. Adipose tissue secretes leptin and adiponectin to regulate bone metabolism. Leptin inhibits bone formation by activating the sympathetic nervous system, whereas the peripheral pathway of leptin shows a positive effect on bone formation. Opposite to leptin, adiponectin enhances or inhibits bone formation osteoblast in the central or peripheral respectively. On the other hand, osteocalcin (OCN) is decarboxylated and released from skeleton as the hormonal form of undercarboxylated-osteocalcin (ucOCN) to stimulate islets and fat to secret insulin and adiponectin respectively, thus to regulate energy metabolism. All these data indicate that there exist complex regulatory loops within fat and bone endocrine networks. In this review, we will elucidate the hormones and their receptors that mediate the communication between fat and bone metabolisms.
Export Options
About this article
Cite this article as:
Wang Chunyu, Tian Li and Yu Xijie, Hormones and their Receptors Bridge Fat and Bone Metabolisms, Current Signal Transduction Therapy 2015; 10 (1) . https://dx.doi.org/10.2174/157436241001150728124635
DOI https://dx.doi.org/10.2174/157436241001150728124635 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease
Current Alzheimer Research The Control of Arterial Hypertension: Epidemiological and Economic Challenge
Current Hypertension Reviews Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
Current Cardiology Reviews Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets Insulin Therapy, Insulin Resistance and Vascular Dysfunction
Current Vascular Pharmacology Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy
Current Drug Therapy The Relationship between Age-Related Kidney Dysfunction and Framingham Risk Score in Healthy People in China
Current Aging Science Pancreatic β-Cells and Type 2 Diabetes Development
Current Diabetes Reviews Identifying the Metabolic Syndrome in Obese Children and Adolescents: Do Age and Definition Matter?
Current Clinical Pharmacology Drug-Metabolizing Enzymes Mechanisms and Functions
Current Drug Metabolism Antihyperlipidemic and Antiobesity Potential of <i>Aquilaria agallocha</i> and <i>Borago officinalis</i> in Fixed-Dose Combination; A Contingent Probe with Atorvastatin and Orlistat
Current Bioactive Compounds Anti-Proliferative Compounds for the Prevention of Restenosis: Anti-Restenotic Mechanisms of Paclitaxel Action
Current Pharmaceutical Design PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Editorial (Sulodexide, An Old Drug with Recent Renewed Interest)
Current Vascular Pharmacology Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction
Current Diabetes Reviews Nutritional Antioxidants and Their Applications in Cardiometabolic Diseases
Infectious Disorders - Drug Targets Current Status of Molecular Imaging in Inflammatory and Autoimmune Disorders
Current Pharmaceutical Design Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis
Current Drug Metabolism